No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Tisotumab Vedotin is Effective as Second- or Third-Line Therapy for Recurrent Cervical Cancer

byAstrid BradshawandAlisha Yi

July 17, 2024

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Tisotumab Vedotin is Effective as Second- or Third-Line Therapy for Recurrent Cervical Cancer

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

All-oral chemotherapy regimen tolerable and efficacious for newly diagnosed acute myeloid leukemia

Image-guided assessment of coronary inflammation improves cardiac risk prediction for patients without obstructive coronary artery disease

RelatedReports

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026

Nivolumab may be effective in platinum-resistant ovarian cancer

Surgery

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

August 9, 2026

No significant increased risk of bladder cancer with pioglitazone use

Oncology

All-oral chemotherapy regimen tolerable and efficacious for newly diagnosed acute myeloid leukemia

July 23, 2026

Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients

Chronic Disease

Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer

July 15, 2026

Stroke expansion following intra-arterial therapy may explain worse outcomes

Reteplase associated with improved functional outcomes in ischemic stroke patients

#VisualAbstract: Temsirolimus Combined with VAC/VI Chemotherapy Did Not Improve Clinical Outcomes of Intermediate-Risk Rhabdomyosarcoma

Extensive lymphadenectomy may not increase patient survival with esophageal cancer

Benralizumab associated with histologic response in eosinophilic esophagitis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Tisotumab Vedotin is Effective as Second- or Third-Line Therapy for Recurrent Cervical Cancer

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

All-oral chemotherapy regimen tolerable and efficacious for newly diagnosed acute myeloid leukemia

Image-guided assessment of coronary inflammation improves cardiac risk prediction for patients without obstructive coronary artery disease

Reteplase associated with improved functional outcomes in ischemic stroke patients

RelatedReports

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

All-oral chemotherapy regimen tolerable and efficacious for newly diagnosed acute myeloid leukemia

Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer

Reteplase associated with improved functional outcomes in ischemic stroke patients

#VisualAbstract: Temsirolimus Combined with VAC/VI Chemotherapy Did Not Improve Clinical Outcomes of Intermediate-Risk Rhabdomyosarcoma

Benralizumab associated with histologic response in eosinophilic esophagitis

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits